PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $75,000 | -7.4% | 23,905 | -13.9% | 0.00% | – |
Q2 2020 | $81,000 | -12.9% | 27,771 | -15.4% | 0.00% | -100.0% |
Q1 2020 | $93,000 | -14.7% | 32,822 | -2.7% | 0.00% | 0.0% |
Q4 2019 | $109,000 | +45.3% | 33,735 | -2.6% | 0.00% | – |
Q3 2019 | $75,000 | -36.4% | 34,619 | -7.9% | 0.00% | -100.0% |
Q2 2019 | $118,000 | -21.3% | 37,570 | -7.0% | 0.00% | 0.0% |
Q1 2019 | $150,000 | +18.1% | 40,398 | -7.4% | 0.00% | 0.0% |
Q4 2018 | $127,000 | +4.1% | 43,638 | -5.9% | 0.00% | 0.0% |
Q3 2018 | $122,000 | -31.1% | 46,369 | -38.7% | 0.00% | 0.0% |
Q2 2018 | $177,000 | -22.0% | 75,687 | -2.1% | 0.00% | 0.0% |
Q1 2018 | $227,000 | -14.3% | 77,347 | -19.9% | 0.00% | 0.0% |
Q4 2017 | $265,000 | +15.2% | 96,587 | +42.7% | 0.00% | 0.0% |
Q3 2017 | $230,000 | -29.0% | 67,703 | -48.4% | 0.00% | 0.0% |
Q2 2017 | $324,000 | +157.1% | 131,224 | +136.8% | 0.00% | 0.0% |
Q1 2017 | $126,000 | +14.5% | 55,423 | +15.3% | 0.00% | 0.0% |
Q4 2016 | $110,000 | -79.6% | 48,087 | -70.1% | 0.00% | -66.7% |
Q3 2016 | $539,000 | +377.0% | 160,903 | +345.7% | 0.00% | +200.0% |
Q2 2016 | $113,000 | +15.3% | 36,100 | +23.2% | 0.00% | 0.0% |
Q1 2016 | $98,000 | +11.4% | 29,291 | +17.2% | 0.00% | 0.0% |
Q4 2015 | $88,000 | -29.6% | 24,997 | +0.7% | 0.00% | 0.0% |
Q3 2015 | $125,000 | -8.8% | 24,821 | +16.7% | 0.00% | 0.0% |
Q2 2015 | $137,000 | +7.9% | 21,273 | +18.2% | 0.00% | 0.0% |
Q1 2015 | $127,000 | -0.8% | 18,000 | +8.4% | 0.00% | 0.0% |
Q4 2014 | $128,000 | +8.5% | 16,600 | +5.0% | 0.00% | 0.0% |
Q3 2014 | $118,000 | -42.4% | 15,804 | -25.2% | 0.00% | 0.0% |
Q2 2014 | $205,000 | +27.3% | 21,131 | +9.0% | 0.00% | 0.0% |
Q1 2014 | $161,000 | -18.7% | 19,392 | -17.2% | 0.00% | 0.0% |
Q4 2013 | $198,000 | +120.0% | 23,433 | +106.8% | 0.00% | – |
Q3 2013 | $90,000 | – | 11,329 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |